LPL Financial »

Crispr Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.1M 108k 46.98
2024-06-30 $6.3M 116k 54.01
2024-03-31 $7.2M 106k 68.16
2023-09-30 $4.1M 91k 45.39
2023-06-30 $5.1M 91k 56.14
2023-03-31 $3.7M 82k 45.23
2022-12-31 $3.2M 78k 40.65
2022-09-30 $5.1M 78k 65.35
2022-06-30 $4.4M 72k 60.78
2022-03-31 $4.1M 65k 62.76
2021-12-31 $4.0M 52k 75.79
2021-09-30 $6.2M 55k 111.93
2021-06-30 $8.0M 50k 161.90
2021-03-31 $5.6M 46k 121.84
2020-12-31 $8.7M 57k 153.12
2020-09-30 $3.1M 37k 83.64
2020-06-30 $4.2M 57k 73.49
2020-03-31 $941k 22k 42.39
2019-12-31 $1.1M 19k 60.90
2019-09-30 $537k 13k 40.98
2019-06-30 $1.6M 33k 47.09
2019-03-31 $295k 8.3k 35.75
2018-12-31 $280k 9.8k 28.55
2018-09-30 $350k 7.9k 44.39
2018-06-30 $396k 6.7k 58.69
2018-03-31 $256k 5.6k 45.63